In this regard, chemotherapeutic drugs, including purine analogs (such as fludarabine) or topoisomerase inhibitors (such as doxorubicin), have been shown to increase p53 level in CLL cells effectively [47, 48]. Here, TP53 is linked to B-cell chronic lymphocytic leukemia.